Xigang Hu

1PUBLICATIONS
4CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 16, 2022
Comprehensive Analysis Identifies PI3K/Akt Pathway Alternations as an Immune-Related Prognostic Biomarker in Colon Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitor Treatment.

Anqi Lin, Tianqi Gu, Xigang Hu

Pageof 1

Frequent Collaborators

1 joint publications

Anqi Lin

1 joint publications

Tianqi Gu

1 joint publications

Jian Zhang

1 joint publications

Peng Luo